Rocket Lab’s Record Backlog Meets a Market That Won’t Stop Selling
Published on 07/28/2026 at 18:22 | Redaktion boerse-global.de
The numbers don’t lie, but they also don’t tell the same story. Rocket Lab’s order book has never been fatter — $2.2 billion in backlog, a 63% revenue surge in the latest quarter, and a freshly signed $266 million contract with the U.S. Space Force. Yet the stock has shed 57.85% of its value since May’s all-time high of €133.80, closing Tuesday at €56.40 after another 4.08% decline. The disconnect between operational momentum and market sentiment has rarely been this stark.
A 14-day relative strength index of 32.8 — firmly in oversold territory — suggests the selling has taken on a life of its own. The annualized 30-day volatility reading of 88.64% underscores just how violent the swings have become. Over the trailing month alone, the stock is down roughly 34%, a rout that has wiped out most of the gains accumulated since last November, when the shares traded as low as €32.60. Even after the drubbing, Rocket Lab still trades 73.01% above that 52-week floor, a reminder that the multi-year uptrend hasn’t entirely collapsed.
The $266 Million Anchor
On July 27, Rocket Lab announced its largest single launch contract ever: a firm order from the Space Systems Command for 12 suborbital HASTE missions, valued at $266 million. Options for six additional launches could push the total to 18 flights. The missions are slated to begin as early as late 2026 and run through December 2028, launching from a new pad at the Pacific Spaceport Complex in Alaska — a strategic expansion beyond the company’s existing facilities in New Zealand and Virginia.
The market rewarded the news with a 4.63% bounce on Monday, lifting the stock to €58.80. But the relief rally was short-lived. Tuesday’s sell-off erased most of that gain, underscoring how deeply the bearish mood has taken hold.
Should investors sell immediately? Or is it worth buying Rocket Lab?
The HASTE contract marks a broader shift in Rocket Lab’s identity. What began as a niche provider of small satellite launches is increasingly becoming a go-to partner for U.S. defense programs. The company’s performance on the “Victus Haze” mission — placing a satellite in orbit just 16 hours after receiving the final launch command — has burnished its credentials for rapid-response, high-stakes government work. Analysts see the combination of launch vehicle, satellite platform, and mission software as a durable competitive advantage in the defense vertical.
The Iridium Overhang
The source of the selling pressure is not hard to find. In late June, Rocket Lab announced its $8 billion acquisition of Iridium Communications, a global provider of voice, data, and navigation services to clients including the U.S. government, Vodafone, and Garmin. The deal — a mix of cash and stock — was intended to give Rocket Lab instant access to IoT and direct-to-device markets, putting it in direct competition with SpaceX’s Starlink. But the market has read the transaction as a dilution and integration risk rather than a strategic coup.
Insider sales have compounded the unease. Several executives have taken profits in recent weeks, a move that rarely calms nervous shareholders. Meanwhile, the June IPO of SpaceX has drawn capital away from the broader space sector, creating a headwind that hits Rocket Lab along with its peers.
Neutron: The Clock Is Ticking
Beneath the day-to-day volatility lies a longer-term anxiety that has been building for months: the repeated delays to the Neutron rocket. The medium-lift vehicle, on which Rocket Lab’s entire growth thesis depends, is now not expected to fly before the fourth quarter of 2026 — the second delay in just over a year, after an earlier target of late 2025 was abandoned. Management maintains the Q4 2026 timeline, but each postponement gives skeptics fresh ammunition.
Five dedicated Neutron flights are already booked. The rocket’s success is essential not only to justify the company’s valuation but to compete with larger launch providers. Until Neutron is actually on the pad, every negative headline will reopen the same wound.
Rocket Lab at a turning point? This analysis reveals what investors need to know now.
What the Analysts Say
Wall Street has largely held its ground. Morgan Stanley maintains an Overweight rating, Citigroup an Outperform. Bank of America has raised its price target, while Citizens and Roth both see the stock heading toward roughly $130. The consensus price target of €100.52 implies upside of about 78% from current levels — a gap that either reflects extraordinary opportunity or a market that sees risks the analyst community has not fully priced in.
Two Dates That Matter
The near-term narrative will be shaped by two milestones. On August 10, Rocket Lab reports quarterly earnings. Investors will be looking for updates on the Iridium integration timeline and the certification status of the Archimedes engine that will power Neutron. Then comes the fourth quarter of 2026, when the Neutron first flight is scheduled — the moment when the company must prove it can execute on its promises.
The Space Force contract provides a short-term floor. But with annualized volatility approaching 89%, the most likely scenario is more violent swings in both directions before the picture clears. For now, Rocket Lab is a company delivering record results in a market that has decided to look the other way.
Ad
Rocket Lab Stock: New Analysis - 28 July
Fresh Rocket Lab information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.
